Patents by Inventor David Minor

David Minor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11981948
    Abstract: Described herein are engineered organelles comprising multi-component proteins from different species incorporated into a membrane structure with interior and exterior aspects. In one embodiment the artificial organelle incorporates one or more protein complexes that absorb optical energy and catalyze electron transfer in biochemical reactions that can be used to reduce NAD+ to NADH or analogues thereof.
    Type: Grant
    Filed: November 2, 2022
    Date of Patent: May 14, 2024
    Assignee: Ensovi, Inc.
    Inventors: Kyle A Minor, Carlo D. Montemagno, David W. Wendell
  • Publication number: 20240132765
    Abstract: The present disclosure relates to refrigeration, air conditioning and heat pump apparatus containing a lubricating composition comprising polyol ester lubricant, tetrafluoropropene and difluoromethane.
    Type: Application
    Filed: January 25, 2022
    Publication date: April 25, 2024
    Applicant: THE CHEMOURS COMPANY FC, LLC
    Inventors: LUKE DAVID SIMONI, BARBARA HAVILAND MINOR
  • Publication number: 20240068003
    Abstract: Described herein are engineered organelles comprising multi-component proteins from different species incorporated into a membrane structure with interior and exterior aspects. In one embodiment the artificial organelle incorporates one or more protein complexes that absorb optical energy and catalyze electron transfer in biochemical reactions that can be used to reduce NAD+ to NADH or analogues thereof.
    Type: Application
    Filed: September 21, 2023
    Publication date: February 29, 2024
    Inventors: Kyle A. Minor, Carlo D. Montemagno, David W. Wendell
  • Patent number: 11907764
    Abstract: Techniques regarding the management of computational resources based on clinical priority associated with one or more computing tasks are provided. For example, one or more embodiments described herein can regard a system comprising a memory that can store computer-executable components. The system can also comprise a processor, operably coupled to the memory, that executes the computer-executable components stored in the memory. The computer-executable components can include a prioritization component that can prioritize computer applications based on a clinical priority of tasks performed by the computer applications. The clinical priority can characterize a time sensitivity of the tasks. The computer-executable components can also include a resource pool component that can divide computational resources across a plurality of resource pools and can assign the computer applications to the plurality of resource pools based on the clinical priority.
    Type: Grant
    Filed: October 7, 2020
    Date of Patent: February 20, 2024
    Assignee: GE PRECISION HEALTHCARE LLC
    Inventors: Evgeny Drapkin, Michael Braunstein, Fausto Espinal, David Minor, Greg Ohme, Ben Dayan, David Chevalier, Manoj Unnikrishnan
  • Publication number: 20210365297
    Abstract: Techniques regarding the management of computational resources based on clinical priority associated with one or more computing tasks are provided. For example, one or more embodiments described herein can regard a system comprising a memory that can store computer-executable components. The system can also comprise a processor, operably coupled to the memory, that executes the computer-executable components stored in the memory. The computer-executable components can include a prioritization component that can prioritize computer applications based on a clinical priority of tasks performed by the computer applications. The clinical priority can characterize a time sensitivity of the tasks. The computer-executable components can also include a resource pool component that can divide computational resources across a plurality of resource pools and can assign the computer applications to the plurality of resource pools based on the clinical priority.
    Type: Application
    Filed: October 7, 2020
    Publication date: November 25, 2021
    Inventors: Evgeny Drapkin, Michael Braunstein, Fausto Espinal, David Minor, Greg Ohme, Ben Dayan, David Chevalier, Manoj Unnikrishnan
  • Patent number: 5639462
    Abstract: An attenuated poliovirus in which the 5' non-coding region of the genome is:(a) the 5' non-coding region of poliovirus type 3 Leon strain modified by the provision of the bases uracil and adenine at positions 472 and 537 thereof respectively, or(b) the 5' non-coding region of another poliovirus modified by the provision of the bases uracil and adenine at respective positions corresponding to position 472 and 537 of the 5' non-coding region of poliovirus type 3 Leon strain.
    Type: Grant
    Filed: May 9, 1994
    Date of Patent: June 17, 1997
    Assignee: British Technology Group Limited
    Inventors: Andrew Joseph MacAdam, Philip David Minor, David Michael Stone, Jeffrey William Almond
  • Patent number: 5639649
    Abstract: An attenuated enterovirus or rhinovirus, suitable for use as a vaccine, has a reversed base pairing in the part, or in a part corresponding to the part, of the 5' non-coding region of the genome of poliovirus type 3 Leon strain shown below: ##STR1## A suitable attenuated poliovirus has the bases G and C at positions 469 and 534 respectively for a type 1 or type 2 poliovirus or at positions 472 and 537 respectively for a type 3 poliovirus.
    Type: Grant
    Filed: February 10, 1995
    Date of Patent: June 17, 1997
    Assignee: Brtish Technology Group Limited
    Inventors: Jeffrey William Almond, Philip David Minor, Michael Anthony Skinner, Colin Ruaraidh Young